Skip to content
  • KOSPI 2676.63 -7.02 -0.26%
  • KOSDAQ 865.59 -1.89 -0.22%
  • KOSPI200 363.58 -0.73 -0.20%
  • USD/KRW 1359 -12 -0.88%
  • JPY100/KRW 888.76 -4.55 -0.51%
  • EUR/KRW 1462.96 -7.78 -0.53%
  • CNH/KRW 188.98 -1.3 -0.68%
View Market Snapshot
Bio & Pharma

LabGenomics unites with Humanscape on Asia, US genetic testing biz

The two companies agreed to combine overseas businesses in Singapore and Vietnam that had been operated separately

By Dec 20, 2022 (Gmt+09:00)

1 Min read

LabGenomics unites with Humanscape on Asia, US genetic testing biz

LabGenomics Co., a molecular diagnostics company, said on Tuesday that it has signed an agreement with digital healthcare company Humanscape to develop a direct-to-consumer genetic testing business in Southeast Asia and the United States.

Humanscape runs Mamitalk, a pregnancy and parenting platform with 600,000 subscribers.

The two companies decided to jointly target overseas markets by utilizing prenatal and postnatal genetic testing services for mothers and babies and the Mamitalk platform's capabilities.

The two parties decided to combine overseas businesses that had been carried out separately in Singapore and Vietnam onto a single platform, establish shared facilities, and make advance preparations with local hospitals.

"It is true there were difficulties in identifying new services and distribution channels while operating prenatal and postpartum exam services overseas. We expect to achieve excellent results in the overseas market soon through cooperation with Humanscape," said a LabGenomics official.

Write to Jeong Min Nam at peux@hankyung.com
More to Read
Comment 0
0/300